Wegovy vs Mounjaro at a Glance
| Comparison | Wegovy injection | Mounjaro injection |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Medication class | GLP-1 receptor agonist | GLP-1 and GIP receptor agonist |
| Primary labeled purpose | Chronic weight management in qualifying patients | Blood-sugar control in adults with type 2 diabetes |
| Traditional weekly maintenance dose | Commonly 1.7 mg or 2.4 mg weekly | Ranges from 5 mg up to 15 mg weekly |
| Weight-loss indication | Yes, for qualifying patients | Not the primary FDA-approved indication (see Zepbound) |
| Common side effects | Nausea, diarrhea, vomiting, constipation, abdominal pain | Nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, abdominal pain |
Understanding the Active Ingredients
Wegovy contains semaglutide, a GLP-1 receptor agonist. It helps regulate appetite, signals fullness and slows stomach emptying.
Mounjaro contains tirzepatide, which activates both GLP-1 and GIP receptors. This dual action affects insulin secretion and appetite regulation.
The most important distinction
A person seeking an FDA-approved treatment specifically for chronic weight management would ordinarily discuss Wegovy. A person with type 2 diabetes needing improved glucose control would ordinarily discuss Mounjaro.
Which One Produces More Weight Loss?
Clinical trial data has often associated tirzepatide with higher average percentages of weight loss than semaglutide, although comparisons between separate trials are imperfect.
Results vary according to dose, duration, starting weight, diet, activity, other conditions and tolerance.
Dosing: Why the Milligrams Matter
Traditional Wegovy injection schedule
Wegovy is typically started at 0.25 mg weekly and gradually increased to a maintenance dosage of 1.7 mg or 2.4 mg.
Traditional Mounjaro injection schedule
Mounjaro is started at 2.5 mg weekly and may be increased in 2.5 mg increments up to 15 mg weekly.
These milligram amounts cannot be compared directly because the medications contain different active ingredients.
Side Effects
- Nausea or reduced appetite
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain, bloating or indigestion
Potential serious risks include pancreatitis, gallbladder problems, dehydration-related kidney injury, serious gastrointestinal reactions, allergic reactions and low blood sugar with certain diabetes medicines.
Cost and Insurance Coverage
What a patient pays depends on insurance, diagnosis, prior authorization, employer benefits and manufacturer programs.
Wegovy is commonly evaluated under obesity-treatment criteria, while Mounjaro is commonly evaluated under diabetes criteria.
Who May Be a Better Candidate for Wegovy?
- Someone meeting the labeled BMI and health-risk criteria.
- Someone without type 2 diabetes seeking an approved weight-management treatment.
- Certain adults with established cardiovascular disease who meet the label criteria.
Who May Be a Better Candidate for Mounjaro?
- An adult with type 2 diabetes needing improved blood-sugar control.
- Someone whose clinician believes tirzepatide is appropriate and whose plan covers it.
Can You Switch Between Wegovy and Mounjaro?
A clinician may transition a patient between products, but they are not dose-for-dose substitutes.
They should not be taken together unless specifically directed by a qualified prescriber.
Looking beyond prescription GLP-1 medications?
Non-prescription wellness products are not substitutes for Wegovy, Mounjaro, diabetes treatment or professional medical care.
Explore the Orygn Wellness OptionBottom Line: Wegovy or Mounjaro?
Wegovy is the clearer fit when the goal is FDA-approved chronic weight management in a qualifying patient. Mounjaro is the clearer fit when the primary clinical need is type 2 diabetes management.
Frequently Asked Questions
Can Mounjaro be prescribed for weight loss?
Doctors sometimes prescribe it off-label. Tirzepatide is also sold as Zepbound, which is specifically approved for chronic weight management.
Are Wegovy and Mounjaro the same medication?
No. Wegovy uses semaglutide, while Mounjaro uses tirzepatide.
Which medication leads to more weight loss?
Separate studies often show higher average weight loss with tirzepatide, although individual results vary.
Which one has fewer side effects?
Their digestive side-effect profiles overlap, and tolerability varies.
Can I switch from Wegovy to Mounjaro?
A switch may be possible under a healthcare provider's supervision.